Source-grounded facts extracted from CNBX Pharmaceuticals Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
CNBX Pharmaceuticals Inc. entered into Promissory Note with 3i L.P. valued at $45,000 (effective 2026-03-10).
“On March 10 th , 2026, the Company executed a non-convertible Promissory Note with 3i L.P., a Delaware Limited Partnership for the amount of $45,000.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.